Publication | Closed Access
AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC).
136
Citations
0
References
2012
Year
Cancer ManagementGynecologyPathologyRecurrent Ovarian CancerGynecology OncologyOvarian CancerOncologyMetronomic TherapyClinical TrialsClinical OncologyRadiation OncologyCancer ResearchMolecular OncologyFinal TextHealth SciencesAsco Daily NewsCancer TreatmentMalignant DiseaseMedicine
LBA5002^ The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Saturday, June 2, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.